T0	Participants 88 116	patients in state hospitals.
T1	Participants 233 284	long-term state hospital inpatients in Connecticut.
T2	Participants 364 409	people experiencing lengthy hospitalizations.
T3	Participants 418 612	Long-stay patients with schizophrenia in a state hospital were randomly assigned to begin open-label clozapine (n = 138) or to continue receiving conventional antipsychotic medications (n = 89).